385 related articles for article (PubMed ID: 19409385)
1. Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma.
Papadopoulos V; Lecanu L
Exp Neurol; 2009 Sep; 219(1):53-7. PubMed ID: 19409385
[TBL] [Abstract][Full Text] [Related]
2. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
[TBL] [Abstract][Full Text] [Related]
3. TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis.
Lejri I; Grimm A; Hallé F; Abarghaz M; Klein C; Maitre M; Schmitt M; Bourguignon JJ; Mensah-Nyagan AG; Bihel F; Eckert A
J Alzheimers Dis; 2019; 72(4):1045-1058. PubMed ID: 31256132
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the mechanisms of neuroprotection mediated by Ro5-4864 in brain injury.
Palzur E; Sharon A; Shehadeh M; Soustiel JF
Neuroscience; 2016 Aug; 329():162-70. PubMed ID: 27223627
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
Taliani S; Pugliesi I; Da Settimo F
Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?
Sullivan PG; Rabchevsky AG; Waldmeier PC; Springer JE
J Neurosci Res; 2005 Jan 1-15; 79(1-2):231-9. PubMed ID: 15573402
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
[TBL] [Abstract][Full Text] [Related]
8. Translocator protein 18 kDa is involved in the regulation of reactive gliosis.
Veiga S; Carrero P; Pernia O; Azcoitia I; Garcia-Segura LM
Glia; 2007 Nov; 55(14):1426-36. PubMed ID: 17674368
[TBL] [Abstract][Full Text] [Related]
9. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
Veenman L; Papadopoulos V; Gavish M
Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
[TBL] [Abstract][Full Text] [Related]
10. A Protective Role of Translocator Protein in Alzheimer's Disease Brain.
Jung ME
Curr Alzheimer Res; 2020; 17(1):3-15. PubMed ID: 32065102
[TBL] [Abstract][Full Text] [Related]
11. Role of mitochondrial translocator protein (18 kDa) on mitochondrial- related cell death processes.
Caballero B; Veenman L; Gavish M
Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):86-101. PubMed ID: 23368281
[TBL] [Abstract][Full Text] [Related]
12. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.
Veenman L; Gavish M
Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies.
Grimm A; Lejri I; Hallé F; Schmitt M; Götz J; Bihel F; Eckert A
J Neuroendocrinol; 2020 Jan; 32(1):e12796. PubMed ID: 31536662
[TBL] [Abstract][Full Text] [Related]
14. Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Da Pozzo E; Giacomelli C; Barresi E; Costa B; Taliani S; Passetti Fda S; Martini C
Biochem Soc Trans; 2015 Aug; 43(4):559-65. PubMed ID: 26551693
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)).
Šileikytė J; Blachly-Dyson E; Sewell R; Carpi A; Menabò R; Di Lisa F; Ricchelli F; Bernardi P; Forte M
J Biol Chem; 2014 May; 289(20):13769-81. PubMed ID: 24692541
[TBL] [Abstract][Full Text] [Related]
16. Targeting mitochondrial energy metabolism with TSPO ligands.
Gut P
Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690
[TBL] [Abstract][Full Text] [Related]
17. [18 kDa translocator protein--implications in cell's functions].
Kołodziejczyk A
Postepy Hig Med Dosw (Online); 2015 Jan; 69():34-50. PubMed ID: 25589712
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic actions of translocator protein (18 kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases.
Arbo BD; Benetti F; Garcia-Segura LM; Ribeiro MF
J Steroid Biochem Mol Biol; 2015 Nov; 154():68-74. PubMed ID: 26200949
[TBL] [Abstract][Full Text] [Related]
19. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis.
Veenman L; Shandalov Y; Gavish M
J Bioenerg Biomembr; 2008 Jun; 40(3):199-205. PubMed ID: 18670869
[TBL] [Abstract][Full Text] [Related]
20. Concentration-dependent bimodal effect of specific 18 kDa translocator protein (TSPO) ligands on cell death processes induced by ammonium chloride: potential implications for neuropathological effects due to hyperammonemia.
Caballero B; Veenman L; Bode J; Leschiner S; Gavish M
CNS Neurol Disord Drug Targets; 2014; 13(4):574-92. PubMed ID: 24168369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
